FI892006A0 - Lactalbumin saosom tillaeggsaemne i mat. - Google Patents

Lactalbumin saosom tillaeggsaemne i mat.

Info

Publication number
FI892006A0
FI892006A0 FI892006A FI892006A FI892006A0 FI 892006 A0 FI892006 A0 FI 892006A0 FI 892006 A FI892006 A FI 892006A FI 892006 A FI892006 A FI 892006A FI 892006 A0 FI892006 A0 FI 892006A0
Authority
FI
Finland
Prior art keywords
tillaeggsaemne
lactalbum
saosom
mat
lactalbumin
Prior art date
Application number
FI892006A
Other languages
English (en)
Other versions
FI892006A (fi
Inventor
Phil Gold
Gustavo Bounous
Patricia L Kongshavn
Original Assignee
Phil Gold
Gustavo Bounous
Patricia L Kongshavn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phil Gold, Gustavo Bounous, Patricia L Kongshavn filed Critical Phil Gold
Publication of FI892006A0 publication Critical patent/FI892006A0/fi
Publication of FI892006A publication Critical patent/FI892006A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese
FI892006A 1988-04-29 1989-04-27 Lactalbumin saosom tillaeggsaemne i mat. FI892006A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18827188A 1988-04-29 1988-04-29
US28997188A 1988-12-23 1988-12-23

Publications (2)

Publication Number Publication Date
FI892006A0 true FI892006A0 (fi) 1989-04-27
FI892006A FI892006A (fi) 1989-10-30

Family

ID=26883894

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892006A FI892006A (fi) 1988-04-29 1989-04-27 Lactalbumin saosom tillaeggsaemne i mat.

Country Status (9)

Country Link
US (2) US5290571A (fi)
EP (1) EP0339656B1 (fi)
JP (1) JP2510724B2 (fi)
AT (1) ATE113474T1 (fi)
CA (1) CA1333471C (fi)
DE (1) DE68919114T2 (fi)
DK (1) DK172782B1 (fi)
ES (1) ES2065352T3 (fi)
FI (1) FI892006A (fi)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
EP1382386A3 (en) * 1992-02-19 2004-12-01 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
WO1993025232A1 (en) * 1992-06-16 1993-12-23 Stolle Research And Development Corporation The use of hyperimmune milk to increase longevity
US6027735A (en) * 1992-07-28 2000-02-22 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
DE4413839C1 (de) * 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
ES2136206T3 (es) 1994-08-16 1999-11-16 Hemant Sabharwal Composicion antibacteriana que contiene alfalactalbumina multimerica.
JP2789554B2 (ja) * 1994-09-26 1998-08-20 全国農業協同組合連合会 免疫活性を有するアルカリ処理ヨーグルト粉末の製造法
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
AU2326297A (en) * 1996-03-06 1997-09-22 I. Belloch Corporation Method for treating liquid materials
IL117505A (en) * 1996-03-15 1999-09-22 Niva Shapira Enriched dairy products
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus
US5882714A (en) * 1996-04-15 1999-03-16 The Iams Company Queens milk replacer
US5792501A (en) * 1996-04-15 1998-08-11 The Iams Company Queen's milk replacer
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
TW517089B (en) * 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
NL1005037C2 (nl) * 1997-01-17 1998-07-20 Nl Zuivelonderzoek Inst Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
US5993866A (en) * 1997-09-12 1999-11-30 Shapira; Niva Process of making food products having reduced methionine ratios
WO1999055326A1 (en) 1998-04-30 1999-11-04 Vit-Immune, L.C. Method of treatment of glutathione deficient mammals
US6667063B2 (en) * 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
US6203805B1 (en) 1998-11-10 2001-03-20 Color Access, Inc. Topical compositions containing whey proteins
EP0951842B1 (en) * 1999-01-20 2002-12-04 N.V. Nutricia Infant formula
US6168819B1 (en) * 1999-04-06 2001-01-02 Kraft Foods, Inc. Cappuccino creamer with improved foaming characteristics
ATE355846T1 (de) * 1999-10-04 2007-03-15 John Carter Pharmazeutische zusammensetzung, die kupfer, salicylsäure und vitamin c enthält
AU2747301A (en) * 1999-11-17 2001-05-30 Tufts University Nutritional supplement systems for populations of women
DK1201137T3 (da) 2000-10-24 2006-07-17 Campina Melkunie Bv Cystein-/glycinrige peptider
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
ES2451618T3 (es) * 2001-12-20 2014-03-28 Biolactis Inc. Matriz de proteína maleable y usos de estas
US20030166866A1 (en) * 2002-01-28 2003-09-04 Land O' Lakes, Inc. Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
US6592908B1 (en) 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20050112177A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
US20050112176A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
EP1638625A4 (en) * 2003-05-23 2009-08-19 David M Ott ORGANOSOUFRES PROMEDICAMENTS FOR PREVENTING AND TREATING INFECTIOUS DISEASES AND A PATHOLOGICAL REACTION OF THE IMMUNE SYSTEM
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
WO2005115173A1 (en) * 2004-05-24 2005-12-08 Ott David M Medicinal products incorporating bound organosulfur groups
KR101233648B1 (ko) * 2004-09-29 2013-02-15 시즈오카켄 유청 단백, 젖 유래의 항체 또는 항체를 포함하는 기능성조성물 또는 식품
US20060115468A1 (en) * 2004-11-26 2006-06-01 Kara Morrison Dietary supplement for treating and preventing gastrointestinal disorders
WO2006127918A2 (en) * 2005-05-24 2006-11-30 Ott David M Personal care and medicinal products incorporating bound organosulfur groups
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20100069288A1 (en) * 2008-09-12 2010-03-18 Wulf Droge Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US20180002374A1 (en) * 2013-03-14 2018-01-04 Green Recovery Technologies, LLC Non-Denatured Proteins Derived From a Biomass Source
CA3038048A1 (en) 2016-09-23 2018-03-29 Immunotec Inc. Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders
CA2970699A1 (en) 2017-06-14 2018-12-14 Elizabeth E. Ignowski Compositions for increasing resilience to traumatic brain injury
US11944649B2 (en) 2017-07-31 2024-04-02 Immunotec Inc. Compositions and methods for treatment of autism spectrum disorder

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH556143A (fr) * 1972-09-11 1974-11-29 Nestle Sa Procede de preparation d'une fraction soluble des proteines du petit lait.
US4043990A (en) * 1974-03-20 1977-08-23 Stauffer Chemical Company Process for the recovery of whey protein having improved solution clarity using polyphosphates
FR2296428A1 (fr) * 1975-01-03 1976-07-30 Baignes Ste Radegonde Laiterie Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
GB1495940A (en) * 1975-02-18 1977-12-21 Grindstedvaerket As Anti-cancer active whey fraction
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
US4497836A (en) * 1982-08-06 1985-02-05 Dairy Technology Ltd. Modified whey product and process including ultrafiltration and demineralization
AU577049B2 (en) * 1983-06-16 1988-09-15 Farley Health Products Limited Infant milk formula
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
US4834974A (en) * 1986-01-13 1989-05-30 Protein Technologies, Inc. Immunologically active whey fraction and recovery process
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
DE3523342A1 (de) * 1985-06-29 1987-01-02 Reinhardt Thyzel Vorrichtung zur laserchirurgie und insbesondere zur keratomie der cornea (i)
JP2623342B2 (ja) * 1989-06-01 1997-06-25 雪印乳業株式会社 脱塩乳類の製造方法

Also Published As

Publication number Publication date
DK172782B1 (da) 1999-07-12
CA1333471C (en) 1994-12-13
EP0339656B1 (en) 1994-11-02
EP0339656A3 (en) 1990-06-20
US5290571A (en) 1994-03-01
FI892006A (fi) 1989-10-30
DE68919114D1 (de) 1994-12-08
US5451412A (en) 1995-09-19
EP0339656A2 (en) 1989-11-02
DE68919114T2 (de) 1995-05-24
JP2510724B2 (ja) 1996-06-26
ATE113474T1 (de) 1994-11-15
DK207489A (da) 1989-10-30
ES2065352T3 (es) 1995-02-16
DK207489D0 (da) 1989-04-28
JPH02152929A (ja) 1990-06-12

Similar Documents

Publication Publication Date Title
FI892006A (fi) Lactalbumin saosom tillaeggsaemne i mat.
DE69016348D1 (de) Leukozyten und Hämoglobin im Blut.
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
FR2634104B1 (fr) Hydrolysat partiel de proteines de lactoserum, procede enzymatique de preparation de cet hydrolysat, et aliment lacte dietetique hypoallergenique le contenant
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
WO2000039299A3 (en) Streptococcus antigens
DE3885459T2 (de) Molkeproteinfraktionen.
EP1757697A3 (en) Group B streptococcus antigens
DE3861987D1 (de) Thermoplastische silikonkautschukpfropfpolymerisate (ii).
ATE163013T1 (de) Alveolare oberflächenaktive proteine
DE3685707T3 (de) In Rubber dispergiertes Copolymerisat.
DE69208537D1 (de) Mittel zur Auftrennung von Blut
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
DE3860646D1 (de) Thermoplastische siliconkautschukpfropfpolymerisate (i).
FR2296428A1 (fr) Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
DE68910100D1 (de) Mittel zur Bluttrennung.
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
DE68913386T2 (de) Selektive enzymatische Zersetzung von beta-Lactoglobulin in Molkeeiweiss von Kuhmilch.
DE3863251D1 (de) Polymerisate mit funktionellen gruppen.
DE3888715T2 (de) Reg-Gen und dadurch kodiertes Protein.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
FR2540107B1 (fr) Nouveaux derives d'halogenobenzophenone-oxime, utilisation en therapeutique et procede de preparation
JPS5753408A (en) Blood coagulation accelerator based on human protein
ATE45067T1 (de) Eiweisshydrolysat.
ATE103635T1 (de) Reg-gen und dadurch kodiertes protein.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: KONGSHAVN, PATRICIA L.

Owner name: GOLD, PHIL

Owner name: BOUNOUS, GUSTAVO